SI
PRNB

Sofinnova Investments’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Sofinnova Investments’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,417,258
Closed -$84.7M – 93
2020
Q2 		$84.7M Hold
1,417,258
– – 5.34% 5
2020
Q1 		$84.2M Hold
1,417,258
– – 7.78% 5
2019
Q4 		$77.6M Hold
1,417,258
– – 5.6% 6
2019
Q3 		$40M Sell
1,417,258
-620,950
-30% -$22.8M 3.62% 7
2019
Q2 		$67.6M Hold
2,038,208
– – 6.22% 4
2019
Q1 		$69.3M Hold
2,038,208
– – 6.68% 3
2018
Q4 		$55.8M Sell
2,038,208
-20,938
-1% -$540K 6.95% 4
2018
Q3 		$59.6M Buy
+2,059,146
New +$58.1M 5.31% 6

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Sofinnova Investments's PRNB Position: Q3 2020 in Review

Sofinnova Investments sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,417,258 shares — an estimated $84.7M sold.

Sofinnova Investments first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $84.7M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Sofinnova Investments reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Sofinnova Investments sold 1,417,258 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $84.7M.
  • Sofinnova Investments first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Sofinnova Investments's Principia Biopharma Inc. Common Stock position peaked at $84.7M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Sofinnova Investments's 13F filing for Q3 2020, filed 13 Nov 2020.